Preferences help
enabled [disable] Abstract
Number of results
2015 | 62 | 2 | 201-206
Article title

Skin metabolism established with the use of MetaSite for selected retinoids employed in topical and systemic treatment of various skin disorders and found in cosmeceuticals

Title variants
Languages of publication
Purpose. Besides being widely used in cosmetics, retinoids are potent therapeutic agents used topically and systemically as anti-acne agents. The aim of this study was to predict with the use of MetaSite the skin metabolism of selected retinoids employed in treatment of skin disorders and found in cosmeceuticals. The following compounds were studied: retinol, retinaldehyde, retinoic acid, retinyl acetate, retinyl palmitate, acitretin, etretinate, adapalene and bexarotene. Methods. MetaSite, Molecular Discovery Ltd. is a computational model that enables prediction of cytochrome P450-dependant metabolism. This software indicates atoms in the molecule structure that are mostly vulnerable to metabolic changes and predicts the metabolite structures. Results. MetaSite indicated that retinol and retinal metabolites were obtained through hydroxylation of the methyl group located in the position 3 of the aliphatic chain, whereas retinoic acid biotransformation would occur principally in the carbon atom situated in the position 4 in the cyclohexene ring. In acitretin molecule, carbon atom of the methoxy group attached to the benzene ring displayed the highest probability of biotransformation. In etretinate, metabolic reactions would occur principally on the carbon atom of the final ethyl group of the molecule. Conclusions. MetaSite metabolism predictions for retinoic acid, acitretin, etretinate, adapalene and bexarotene were in agreement with experimental findings. In case of compounds being converted by catalysts other than cytochrome P450 enzymes, the primary metabolites predicted by MetaSite differ from those reported previously. In conclusion, MetaSite is a useful tool that can aid identification of the major metabolites of compounds being administered topically.
Physical description
  • Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
  • Department of Bioorganic Chemistry, Chair of Organic Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
  • Department of Bioorganic Chemistry, Chair of Organic Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
  • Department of Bioorganic Chemistry, Chair of Organic Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
  • Department of Bioorganic Chemistry, Chair of Organic Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
  • Ayala FA (08.08.2006) Patent US20090318371 A1, Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and/or keratolytic (microsponged benzoyl peroxide).
  • Babamiri K, Nassab R (2010) Cosmeceuticals: the evidence behind the retinoids. Aesthet Surg J 30: 74-77.
  • Baron JM, Heise R, Blaner WS, Neis M, Joussen S, Dreuw A, Marquardt Y, Saurat JH, Merk HF, Bickers DR, Jugert FK (2005) Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol 125: 143-153.
  • Baron JM, Wiederholt T, Heise R, Merk HF, Bickers DR (2008) Expression and function of cytochrome p450-dependent enzymes in human skin cells. Curr Med Chem 15: 2258-2264.
  • Boehnlein J, Sakr A, Lichtin JL, Bronaugh RL (1994) Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption. Pharm Res 11: 1155-1159.
  • Blomhoff R, Blomhoff HK (2006) Overview of retinoid metabolism and function. J Neurobiol 66: 606-630.
  • Cruciani G, Carosati E, De Boeck B, Ethirajulu K, Mackie C, Howe T, Vianello R (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 48: 6970-6979.
  • Brun PJ, Yang KJ, Lee SA, Yuen JJ, Blaner WS (2013) Retinoids: Potent regulators of metabolism. Biofactors 39: 151-163.
  • Conaway HH, Henning P, Lerner UH (2013) Vitamin a metabolism, action, and role in skeletal homeostasis. Endocr Rev 34: 766-797.
  • Draelos ZD (2005) Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. Dermatol Surg 31: 799-804.
  • Duell EA, Kang S, Voorhees JJ (1996) Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid. J Invest Dermatol 106: 316-320.
  • Hellmann-Regen J, Kronenberg G, Uhlemann R, Freyer D, Endres M, Gertz K (2013) Accelerated degradation of retinoic acid by activated microglia. J Neuroimmunol 256: 1-6.
  • Howell SR, Shirley MA, Grese TA, Neel DA, Wells KE, Ulm EH (2001) Bexarotene metabolism in rat, dog, and human, synthesis of oxidative metabolites, and in vitro activity at retinoid receptors. Drug Metab Dispos 29: 990-998.
  • Hubbard BA, Unger JG, Rohrich RJ (2014) Reversal of skin aging with topical retinoids. Plast Reconstr Surg 133: 481e-490e.
  • Ianhez M, Fleury LF Jr, Miot HA, Bagatin E (2013) Retinoids for prevention and treatment of actinic keratosis. An Bras Dermatol 88: 585-593.
  • Jean J, Soucy J, Pouliot R (2011) Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model. Tissue Eng. Part A 17: 1859-1868.
  • Kang S, Duell EA, Fisher GJ, Datta SC, Wang ZQ, Reddy AP, Tavakkol A, Yi JY, Griffiths CE, Elder JT, Voorhees JJ (1995) Application of retinol to human skin in vivo induces epidermal hyperplasia and cellular retinoid binding proteins characteristic of retinoic acid but without measurable retinoic acid levels or irritation. J Invest Dermatol 105: 549-556.
  • Kang S, Bergfeld W, Gottlieb AB, Hickman J, Humeniuk J, Kempers S, Lebwohl M, Lowe N, McMichael A, Milbauer J, Phillips T, Powers J, Rodriguez D, Savin R, Shavin J, Sherer D, Silvis N, Weinstein R, Weiss J, Hammerberg C, Fisher GJ, Nighland M, Grossman R, Nyirady J (2005) Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. Am J Clin Dermatol 6: 245-253.
  • Kim MS, Lee S, Rho HS, Kim DH, Chang IS, Chung JH (2005) The effects of a novel synthetic retinoid, seletinoid G, on the expression of extracellular matrix proteins in aged human skin in vivo. Clin Chim Acta 362: 161-169.
  • Kirchmair J, Williamson MJ, Tyzack JD, Tan L, Bond PJ, Bender A, Glen RC (2012) Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inf Model 52: 617-648.
  • Kircik LH (2012) Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study. J Drugs Dermatol 11: 83-90.
  • Kurlandsky SB, Xiao JH, Duell EA, Voorhees JJ, Fisher GJ (1994) Biological activity of all-trans retinol requires metabolic conversion to all-trans retinoic acid and is mediated through activation of nuclear retinoid receptors in human keratinocytes. J Biol Chem 269: 32821-32827.
  • Kurlandsky SB, Duell EA, Kang S, Voorhees JJ, Fisher GJ (1996) Auto-regulation of retinoic acid biosynthesis through regulation of retinol esterification in human keratinocytes. J Biol Chem 271: 15346-15352.
  • Langowski J, Long A (2002) Computer systems for the prediction of xenobiotic metabolism. Adv Drug Deliv Rev 54: 407-415.
  • Millikan LE (2005) Drug Therapy in Dermatology (Basic and Clinical Dermatology). Taylor & Francis e-library.
  • Molecular Discovery Ltd.,
  • Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G (2006) Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging 1: 327-348.
  • Nyirady J, Bergfeld W, Ellis C, Levine N, Savin R, Shavin J, Voorhees JJ, Weiss J, Grossman R (2001) Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies. Cutis 68: 135-142.
  • O'Byrne SM, Blaner WS (2013) Retinol and retinyl esters: biochemistry and physiology. J Lipid Res 54: 1731-1743.
  • Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C., Landsiedel R (2007) Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev 39: 659-698.
  • Reynolds NJ, Fisher GJ, Griffiths CE, Tavakkol A, Talwar HS, Rowse PE, Hamilton TA, Voorhees JJ (1993) Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo. J Pharmacol Exp Ther 266: 1636-1642.
  • Roos TC, Jugert FK, Merk HF, Bickers DR (1998) Retinoid metabolism in the skin. Pharmacol Rev 50: 315-333.
  • Rossetti D, Kielmanowicz MG, Vigodman S, Hu YP, Chen N, Nkengne A, Oddos T, Fischer D, Seiberg M, Lin CB (2011) A novel anti-ageing mechanism for retinol: induction of dermal elastin synthesis and elastin fibre formation. Int J Cosmet Sci 33: 62-69.
  • Sarkar R, Chugh S, Garg VK (2013) Acitretin in dermatology. Indian J Dermatol Venereol Leprol 79: 759-771.
  • Serri R, Iorizzo M (2008) Cosmeceuticals: focus on topical retinoids in photoaging. Clin Dermatol 26: 633-635.
  • Siegenthaler G, Saurat JH, Ponec M (1990) Retinol and retinal metabolism. Relationship to the state of differentiation of cultured human keratinocytes. Biochem J 268: 371-378.
  • Sorg O, Didierjean L, Saurat JH (1999) Metabolism of topical retinaldehyde. Dermatology 199 (Suppl 1): 13-17.
  • Sorg O, Antille C, Kaya G, Saurat JH (2006) Retinoids in cosmeceuticals. Dermatol Ther 19: 289-296.
  • Svensson CK (2009) Biotransformation of drugs in human skin. Drug Metab Dispos 37: 247-253.
  • Törmä H, Vahlquist A (1990) Vitamin A esterification in human epidermis: a relation to keratinocyte differentiation. J Invest Dermatol 94: 132-138.
  • Varani J, Mitra RS, Gibbs D, Phan SH, Dixit VM, Mitra R Jr, Wang T, Siebert KJ, Nickoloff BJ, Voorhees JJ (1990) All-trans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol 94: 717-723.
  • Varani J, Warner RL, Gharaee-Kermani M, Phan SH, Kang S, Chung JH, Wang ZQ, Datta SC, Fisher GJ, Voorhees JJ (2000) Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 114: 480-486.
  • von Lintig J (2012) Metabolism of carotenoids and retinoids related to vision. J Biol Chem 287: 1627-1634.
  • Westin S, Mode A, Murray M, Chen R, Gustafsson JA (1993) Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes. Mol Pharmacol 44: 997-1002.
  • Zhou D, Afzelius L, Grimm SW, Andersson TB, Zauhar RJ, Zamora I (2006) Comparison of methods for the prediction of the metabolic sites for CYP3A4-mediated metabolic reactions. Drug Metab Dispos 34: 976–983.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.